Silvi Telo
University of Bologna
CancerInternal medicineRadiologyUrologyPET-CTMolecular imagingOncologyPerfusionAntigenOdds ratioCohen's kappaInfection controlSocial distanceStage (cooking)In vivoPathologicalPositron emission tomographyTeratomaTesticular cancerLung cancerChemotherapyAcute leukemiaRadical surgeryBiochemical recurrenceFluorodeoxyglucoseBrachytherapyBiodistributionSeminomaWorkforceCervical cancerSuspectMerkel cell carcinomaRadiomicsResearch developmentNeuroendocrine tumorsProstatectomyMEDLINETelemedicineSingle CenterProstate cancerPrimary tumorPersonal protective equipmentProgression-free survivalManagement of prostate cancerCholinePopulationTesticular tumoursRecurrent prostate cancer188 Rhenium11C-choline68Ga-DOTANOCToxicityHigh energyNuclear medicineTreatment responsePersonalized therapyRadionuclide therapyPet imagingPeptide receptorIn patientNon melanomaFood and drug administrationPsma petAfter treatmentPersonal hygieneMedical imagingComputer scienceIncidence (epidemiology)Confidence intervalCancer researchRadiation therapyInterventional radiologyClinical trialComputed tomographyImage qualityMedicineCohortPandemic
13Publications
2H-index
14Citations
Publications 14
Newest
#1Margarita KirienkoH-Index: 20
#2Silvi Telo (UNIBO: University of Bologna)H-Index: 2
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 6 authors...
The COVID-19 pandemic has profoundly changed hospital activities, including nuclear medicine (NM) practice. This review aimed to determine and describe the impact of COVID-19 on NM in Europe and critically discuss actions and strategies applied to face the pandemic. A literature search for relevant articles was performed on PubMed, covering COVID-19 studies published up until January 21, 2021. The findings were summarized according to general and specific activities within the NM departments. Th...
Source
#1Silvi Telo (UNIBO: University of Bologna)H-Index: 2
#2Angelina FiliceH-Index: 12
Last. Valentina Ambrosini (UNIBO: University of Bologna)H-Index: 42
view all 8 authors...
Aim of the present review is to analyze the most relevant achievements of peptide receptor radionuclide therapy (PRRT) in neuroendocrine neoplasms (NENs) management, focusing on treatment efficacy as well as toxicity and taking into account the innovative applications and future perspectives. A comprehensive literature review of PubMed/Medline (last updated January 2021) was performed using a combination of the following keywords: PRRT, NEN/NET treatment, somatostatin analogues, PET/CT [68Ga]Ga-...
Source
#1Andrea Farolfi (UNIBO: University of Bologna)H-Index: 8
#2Letizia Calderoni (UNIBO: University of Bologna)H-Index: 2
Last. Paolo Castellucci (UNIBO: University of Bologna)H-Index: 54
view all 7 authors...
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer (PCa) cells and several PSMA ligands for PET imaging (PSMA-PET) are now available worldwide. 68Ga-PSMA-11 has already received American Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval, and PSMA-PET is currently suggested by several international guidelines to investigate PCa in different clinical settings. In primary PCa, PSMA-PET has been shown to be superior to cross-sectional ...
4 CitationsSource
#1Andrea FarolfiH-Index: 8
#2Silvi TeloH-Index: 2
Last. Deandreis D (UNITO: University of Turin)
view all 16 authors...
Coronavirus disease 2019 (COVID-19) pathology is associated with neoangiogenesis and interstitial pneumonia. 68Ga-PSMA-11-PET/CT is able to image in vivo PSMA (Prostate-Specific Membrane Antigen) expression on both prostate cancer (PCa) cells and neovasculature endothelial cells. The aim of the case series was to explore pulmonary PSMA expression not related to cancer in patients with PCa and concomitant COVID-19. In this retrospective, multicenter case series, patients who underwent 68Ga-PSMA-1...
#6L. Gianolli (University of Milan)H-Index: 1
#10Paola Mapelli (University of Milan)
OBJECTIVE Several studies have reported about the performance of C-choline-PET/computed tomography (CT) (choline) in patients with biochemical recurrent (BCR) prostate cancer, but there is a lack of information regarding negative choline in the same clinical setting. Our aim was to retrospectively analyse negative choline in a cohort of BCR-patients with high prostate-specific antigen (PSA). METHODS AND RESULTS We retrospectively analysed all choline-scans performed at two high-volume imaging ce...
Source
#1Diletta Calabrò (UNIBO: University of Bologna)H-Index: 2
#2Silvi TeloH-Index: 2
Last. Valentina AmbrosiniH-Index: 6
view all 3 authors...
PURPOSE OF REVIEW Testicular cancer is rare, but its incidence is expected to rise. [18F] fluorodeoxyglucose ([18F]FDG) PET/computed tomography (CT) added role in testicular cancer management has been defined in a set of specific clinical settings. The current review focuses on recent advances in the employment of PET/CT in testicular cancer patients. RECENT FINDINGS [18F]FDG PET/CT is not recommended for initial staging or for suspected testicular tumours. PET/CT role in testicular cancer manag...
2 CitationsSource
#1Letizia Calderoni (UNIBO: University of Bologna)H-Index: 2
#2Andrea Farolfi (UNIBO: University of Bologna)H-Index: 8
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 11 authors...
: Introduction:68Ga-labeled urea-based inhibitors of the prostate-specific membrane antigen (PSMA), such as 68Ga-PSMA-11, are promising small molecules for targeting prostate cancer (PCa). Although this radiopharmaceutical was mostly produced by the means of automated synthesis modules, a sterile cold kit was recently introduced. The aim of our study was to evaluate the image quality of 68Ga-PSMA-11 PET/CT (PSMA-PET) in a population of PCa patients following the injection of comparable activitie...
10 CitationsSource
#1Anna Myriam Perrone (UNIBO: University of Bologna)H-Index: 20
#2Giulia Dondi (UNIBO: University of Bologna)H-Index: 5
Last. Pierandrea De Iaco (UNIBO: University of Bologna)H-Index: 24
view all 13 authors...
Tumor response in locally advanced cervical cancer (LACC) is generally evaluated with MRI and PET, but this strategy is not supported by the literature. Therefore, we compared the diagnostic performance of these two techniques in the response evaluation to concurrent chemoradiotherapy (CCRT) in LACC. Patients with cervical cancer (CC) stage T2b treated with CCRT and submitted to MRI and PET/CT before and after treatment were enrolled in the study. All clinical, pathological, therapeutic, radiolo...
3 CitationsSource
#5Silvi TeloH-Index: 2
#1Silvi Telo (UNIBO: University of Bologna)H-Index: 2
#2Letizia Calderoni (UNIBO: University of Bologna)H-Index: 2
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 6 authors...
BACKGROUND: FDG PET/CT imaging has an established role in lung cancer (LC) management. Whilst is a sensitive technique, FDG PET/CT has a limited specificity in the differentiation between LC and benign conditions and is not capable of defining LC heterogeneity since FDG uptake varies between hystotypes. OBJECTIVE: To get an overview about new radiopharmaceuticals for the study of cancer biology features beyond glucose metabolism in LC. METHODS: A comprehensive literature review of PubMed/Medline...
2 CitationsSource